Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 49, pseudogene (RN7SL49P) is a pseudogene derived from the 7SL RNA gene, which is a component of the signal recognition particle (SRP) complex involved in the cotranslational targeting of secretory proteins to the endoplasmic reticulum[3][1][4]. 7SL RNA pseudogenes, of which there are many copies in the human genome, typically arise from reverse transcription events and are generally not expressed or functional; they do not encode protein and do not function as receptors, enzymes, or other canonical drug targets[4]. RN7SL49P itself is one of these nonfunctional genomic sequences with sequence similarity to the functional 7SL RNA gene, but has no known biological function or disease association, and is not a therapeutic target[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 49, pseudogene (RN7SL49P).